Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations') - Receipt Of Request Seeking Re-Classification From 'Promoter Group' Category To 'Public Shareholder' Category Of Piramal Pharma Limited ('The Company')

 Disclosure under Regulation 30 read with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations') - Receipt of request seeking re-classification from 'Promoter Group' category to 'Public Shareholder' category of Piramal Pharma Limited ('the Company')
02-02-2023
Bigul

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Conference Call with Investors/Analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 ('Listing Regulations')
01-02-2023
Bigul

Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Intimation Under Regulation 29 And Regulation 50 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve Pursuant to Regulations 29 and 50 of the Listing Regulations, we write to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 08th February, 2023, inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended 31st December, 2022.
01-02-2023
Bigul

Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA Inspection at Sellersville site.
14-01-2023
Bigul

Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA Inspection at lexington Site
11-01-2023
Bigul

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Investor Presentation under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
05-01-2023
Bigul

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
03-01-2023
Bigul

Piramal Pharma Ltd - 543635 - Compliance Under Regulation 23 (9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)

 Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed herewith disclosure of related party transactions for the half year ended 30th September, 2022.
22-11-2022
Bigul

Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG, Singapore Branch , DBX Advisors LLC
14-11-2022
Bigul

Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG, Singapore Branch, DBX Advisors LLC
14-11-2022
Next Page
Close

Let's Open Free Demat Account